View in EDS HTML Full Text PDF Full Text

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.

Saved in:
Bibliographic Details
Title: Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.
Authors: Brown, Michelle L1 (AUTHOR), Motsch, Johann2 (AUTHOR), Kaye, Keith S3 (AUTHOR), File, Thomas M4 (AUTHOR), Boucher, Helen W5 (AUTHOR), Vendetti, Neika1 (AUTHOR), Aggrey, Angela1 (AUTHOR), Joeng, Hee-Koung1 (AUTHOR), Tipping, Robert W1 (AUTHOR), Du, Jiejun1 (AUTHOR), DePestel, Daryl D1 (AUTHOR), Butterton, Joan R1 (AUTHOR), Paschke, Amanda1 (AUTHOR) amanda.paschke@merck.com
Source: Open Forum Infectious Diseases. Mar2020, Vol. 7 Issue 3, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofaa054